** Shares of telehealth firm Hims and Hers HIMS.N rise 16.1% to $67.94
** Co acquires at-home lab testing service Trybe Labs, which offers at-home blood draws and whole body testing for subscribers
** With at-home lab testing, customers will be able to access more information about their health and providers can recommend high-quality customized treatments - HIMS
** HIMS expects to roll out at-home testing over the next year
** HIMS funded the acquisition through cash on hand
** "All-in, our general view is that we need to hear more. Seeing a category expansion, or in this case service expansion, is not a surprise on the surface" - brokerage Leerink Partners
** Stock has risen 6x in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))